Brief: NRx Responds To Relief’s Allegations Of January 14, 2022
Jan 14 (Reuters) - NRx Pharmaceuticals Inc NRXP.O :
* NRX RESPONDS TO RELIEF’S ALLEGATIONS OF JANUARY 14, 2022
* NRX PHARMACEUTICALS INC - LOOKS FORWARD TO MEETING RELIEF IN MEDIATION ON
FEBRUARY 22
Source text for Eikon: ID:nGNX2jng5W
Further company coverage: NRXP.O
((Reuters.Briefs@thomsonreuters.com;))
Recent news on MindMaze Therapeutics Holding SA
See all newsBrief: Mindmaze Therapeutics Announces CHF 8.0 Million Strategic Equity Financing
Brief: Relief Therapeutics Shareholders Approve Business Combination With Neurox
Brief: Relief Therapeutics Receives FDA Response To Qidp Request For Rlf-Td011
Brief: Relief Therapeutics Says Interim CEO Michelle Lock Has Completed Her Transitional Mandate
Swiss stocks - Factors to watch on May 13